Ana
Fernández Montes
![Foto de Ana](/img/nophoto.png)
![Foto de Hospital Virgen del Camino](/img/noimage_org.png)
Hospital Virgen del Camino
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Hospital Virgen del Camino (7)
2023
-
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study
PLoS ONE, Vol. 18, Núm. 5 May
-
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
Therapeutic Advances in Medical Oncology, Vol. 15
2021
-
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 988-1000
2020
-
Maintenance treatment in metastatic colorectal cancer: in search of the best strategy
Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1205-1215
-
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry
Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 734-750
2018
-
Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
Journal of Geriatric Oncology, Vol. 9, Núm. 3, pp. 254-264
2016
-
On the effect of triplet or doublet chemotherapy in advanced gastric cancer: Results from a national cancer registry
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 11, pp. 1379-1388